Literature DB >> 16093757

The use of stress echocardiography for prognostication in coronary artery disease: an overview.

Elena Biagini1, Abdou Elhendy, Jeroen J Bax, Arend F L Schinkel, Don Poldermans.   

Abstract

PURPOSE OF REVIEW: Stress echocardiography has a high accuracy for the detection of coronary artery disease. Additionally, it provides clinically useful prognostic information, such as resting left ventricular function, myocardial viability, stress-induced ischemia, vascular extent of wall motion abnormalities, and changes in end-systolic volume and ejection fraction with stress. RECENT DEVELOPMENTS: The timing, extent, and severity of the stress-induced wall motion abnormalities are important determinants of long-term prognosis. Previous studies have shown the efficacy of stress echocardiography in predicting long-term cardiac events in mixed patient groups and the value of this test in selected patient subsets.
SUMMARY: This review attempts to define the role of stress echocardiography for prognostication in coronary artery disease, pointing out the ability of this technique to identify low-risk and high-risk subsets among patients with known or suspected coronary artery disease and thus guide patient management decisions.

Entities:  

Mesh:

Year:  2005        PMID: 16093757     DOI: 10.1097/01.hco.0000175516.50181.c0

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  2 in total

1.  Effect of serum uric acid on the positive predictive value of dobutamine stress echocardiography.

Authors:  Alpay Aribas; Hakan Akilli; Mehmet Kayrak; Hayrudin Alibasic; Oguzhan Yildirim; Ahmet Lutfi Sertdemir; Mustafa Karanfil; Kurtulus Ozdemir
Journal:  Heart Vessels       Date:  2014-12-11       Impact factor: 2.037

2.  Quantitative three-dimensional wall motion analysis predicts ischemic region size and location.

Authors:  Susan L Herz; Takuya Hasegawa; Amgad N Makaryus; Katherine M Parker; Shunichi Homma; Jie Wang; Jeffrey W Holmes
Journal:  Ann Biomed Eng       Date:  2010-01-13       Impact factor: 3.934

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.